Rituximab
RITAZAREM
Phase 3 mab completed
Quick answer
Rituximab for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis is a Phase 3 program (mab) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- Phase
- Phase 3
- Modality
- mab
- Status
- completed